Dr. Tap on Olaratumab in Patients With Soft Tissue Sarcoma
1 Visualizzazioni
• 07/18/23
0
0
Incorporare
administrator
Iscritti
William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the mechanism of action of olaratumumab as a treatment for patients with soft tissue sarcoma.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti